Intraoperative radiotherapy during awake craniotomies: preliminary results of a single-center case series.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 26 05 2022
accepted: 18 07 2022
revised: 06 07 2022
pubmed: 27 7 2022
medline: 18 11 2022
entrez: 26 7 2022
Statut: ppublish

Résumé

Awake craniotomies are performed to avoid postoperative neurological deficits when resecting lesions in the eloquent cortex, especially the speech area. Intraoperative radiotherapy (IORT) has recently focused on optimizing the oncological treatment of primary malignant brain tumors and metastases. Herein, for the first time, we present preliminary results of IORT in the setting of awake craniotomies. From 2021 to 2022, all patients undergoing awake craniotomies for tumor resection combined with IORT were analyzed retrospectively. Demographical and clinical data, operative procedure, and treatment-related complications were evaluated. Five patients were identified (age (mean ± standard deviation (SD): 65 ± 13.5 years (y)). A solid left frontal metastasis was detected in the first patient (female, 49 y). The second patient (male, 72 y) presented with a solid metastasis on the left parietal lobe. The third patient (male, 52 y) was diagnosed with a left temporoparietal metastasis. Patient four (male, 74 y) was diagnosed with a high-grade glioma on the left frontal lobe. A metastasis on the left temporooccipital lobe was detected in the fifth patient (male, 78 y). After awake craniotomy and macroscopic complete tumor resection, intraoperative tumor bed irradiation was carried out with 50 kV x-rays and a total of 20 Gy for 16.7 ± 2.5 min. During a mean follow-up of 6.3 ± 2.6 months, none of the patients developed any surgery- or IORT-related complications or disabling permanent neurological deficits. Intraoperative radiotherapy in combination with awake craniotomy seems to be feasible and safe.

Identifiants

pubmed: 35881316
doi: 10.1007/s10143-022-01838-9
pii: 10.1007/s10143-022-01838-9
pmc: PMC9663365
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3657-3663

Informations de copyright

© 2022. The Author(s).

Références

Front Oncol. 2021 Nov 11;11:768168
pubmed: 34858846
J Clin Neurosci. 2021 Nov;93:36-41
pubmed: 34656258
Cochrane Database Syst Rev. 2018 Aug 20;8:CD012086
pubmed: 30125049
J Neurooncol. 2019 Nov;145(2):391-397
pubmed: 31654248
Curr Opin Anaesthesiol. 2018 Oct;31(5):506-510
pubmed: 29994938
Neurooncol Adv. 2020 Sep 18;2(1):vdaa111
pubmed: 33063012
J Neurooncol. 2018 Nov;140(2):413-420
pubmed: 30094718
Anaesthesist. 2015 Feb;64(2):128-36
pubmed: 25421054
Cancer Med. 2018 Jun;7(6):2350-2359
pubmed: 29745035
Neurosurgery. 2019 Jan 1;84(1):41-49
pubmed: 29528443
Neurosurgery. 2013 Jul;73(1):135-40; discussion 140
pubmed: 23615101
Neurosurgery. 2017 Sep 1;81(3):481-489
pubmed: 28327900
Acta Neurochir (Wien). 2019 Feb;161(2):307-315
pubmed: 30617715
J Clin Oncol. 2012 Jul 10;30(20):2559-65
pubmed: 22529254
PLoS One. 2016 May 26;11(5):e0156448
pubmed: 27228013
Strahlenther Onkol. 2021 Dec;197(12):1124-1130
pubmed: 34415358

Auteurs

K Steininger (K)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany. kathrin.steininger@uk-augsburg.de.

K H Kahl (KH)

Department of Radiation Therapy, University Hospital Augsburg, Augsburg, Germany.

I Konietzko (I)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

C Wolfert (C)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

S Motov (S)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

P E Krauß (PE)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

T Bröcheler (T)

Department of Anesthesia, University Hospital Augsburg, Augsburg, Germany.

M Hadrawa (M)

Department of Anesthesia, University Hospital Augsburg, Augsburg, Germany.

B Sommer (B)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

G Stüben (G)

Department of Radiation Therapy, University Hospital Augsburg, Augsburg, Germany.

E Shiban (E)

Department of Neurosurgery, University Hospital Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH